Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Ribocure Pharmaceuticals AB
AB
Active
Org 5593664377
Vetenskapens Gränd 11, 431 53
Mölndal
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2022 · 4 years old
50-99 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Ribocure Pharmaceuticals AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
LM
Li Ming Gan
Chief Executive Officer
Chief Executive Officer
2022
NC
Nina Charlotte Angard
Chief Auditor
Chief Auditor
2024
Former (1)
MG
Mattias Gustaf Erik Olofson
Chief Auditor
Chief Auditor
2022 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
ZL
Zicai Liang
Chairman
Chairman
2022
KE
Kjell Erik Torne Selin
Board of Directors
Board of Directors
2025
HY
Hong Yan Zhang
Board of Directors
Board of Directors
2022
LM
Li Ming Gan
Board of Directors
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Ribocure Pharmaceuticals AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
